About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 12 record(s)
Req # A-2023-01972
SJS2023-0010637 - Classified Global Integrated Wargame (GIWG) Briefing Note. - Dec 4, 2023Organization: National Defence
February 2024
Req # A-2023-01991
SJS2023-0010637 - Classified Global Integrated Wargame (GIWG) Briefing Note. - Dec 4, 2023Organization: National Defence
February 2024
Req # A-2022-01330
ASSOCDM2022-0010140: Briefing note for the vice minister on the Lesbian, Gay, Bisexual and Transgender PurgeOrganization: National Defence
February 2023
Req # A-2021-001600
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Certified Product Information Document.Organization: Health Canada
February 2022
Req # A-2021-001601
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Batch Formula” (3.2.P.3.2).Organization: Health Canada
February 2022
Req # A-2021-001602
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Description of Manufacturing Process and Process Controls” (3.2.P.3.3).Organization: Health Canada
February 2022
Req # A-2021-001605
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Product Monograph.Organization: Health Canada
February 2022
Req # A-2020-01836
Briefing Note: Official Languages Complaint – [REDACTED] 2021-01-22 Ref. No.: IM2020-0017508Organization: National Defence
February 2022
Req # A-2019-01054
CC115 Buffalo Aircraft Structural Integrity Program - Master Plan - 1985Organization: National Defence
February 2021
Req # A-2019-000740
All documents submitted by Sandoz Canada Inc. in Electronic Common Technical Document (eCTD) Module 1.6.1 (Comparative Bioavailability Information) of any Abbreviated New Drug Submissions made by Sandoz Canada Inc. for its GLATOPA product (glatiramer acetate).Organization: Health Canada
February 2020